Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel K Benjamin

Showing results (271-280 of 362) with videos related to

Pageof 37
Sort By:
The Pediatric Infectious Disease Journal|June 20, 2024
Postdiscontinuation Antibiotic Exposure in Hospitalized Infants at Risk for Late-onset Sepsis in the Neonatal Intensive Care UnitKelly C Wade, Rachel G Greenberg, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
Rifampin Pharmacokinetics and Safety in Preterm and Term InfantsP Brian Smith, C Michael Cotten, Mark L Hudak, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2019
Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous <i>Candida</i> MeningoencephalitisVidmantas Petraitis, Ruta Petraitiene, Jessica M Valdez, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation InitiativeRachel G Greenberg, Amy Corneli, John Bradley, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic ModelsMichael F Hwang, Ryan J Beechinor, Kelly C Wade, et al.
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 26, 2024
Epidemiology and outcomes of bacterial meningitis in the neonatal intensive care unitSamia Aleem, Daniel K Benjamin, Charles M Burns, et al.
The Pediatric Infectious Disease Journal|March 30, 2018
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive CandidiasisDaniel K Benjamin, David A Kaufman, William W Hope, et al.
Early Human Development|June 28, 2022
Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus diseaseJessica E Ericson, Daniel K Benjamin, Felix Boakye-Agyeman, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study designAdriana Tremoulet, Jennifer Le, Brenda Poindexter, et al.
Pageof 37

Showing results (271-280 of 362) with videos related to

Sort By:
Pageof 37
The Pediatric Infectious Disease Journal|June 20, 2024
Postdiscontinuation Antibiotic Exposure in Hospitalized Infants at Risk for Late-onset Sepsis in the Neonatal Intensive Care UnitKelly C Wade, Rachel G Greenberg, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
Rifampin Pharmacokinetics and Safety in Preterm and Term InfantsP Brian Smith, C Michael Cotten, Mark L Hudak, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2019
Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous <i>Candida</i> MeningoencephalitisVidmantas Petraitis, Ruta Petraitiene, Jessica M Valdez, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation InitiativeRachel G Greenberg, Amy Corneli, John Bradley, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic ModelsMichael F Hwang, Ryan J Beechinor, Kelly C Wade, et al.
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 26, 2024
Epidemiology and outcomes of bacterial meningitis in the neonatal intensive care unitSamia Aleem, Daniel K Benjamin, Charles M Burns, et al.
The Pediatric Infectious Disease Journal|March 30, 2018
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive CandidiasisDaniel K Benjamin, David A Kaufman, William W Hope, et al.
Early Human Development|June 28, 2022
Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus diseaseJessica E Ericson, Daniel K Benjamin, Felix Boakye-Agyeman, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study designAdriana Tremoulet, Jennifer Le, Brenda Poindexter, et al.
Pageof 37